Clinical characteristics of people living with HIV/AIDS attending antiretroviral therapy clinic at University of Gondar Hospital, University of Gondar, Northwest Ethiopia, 2019 (n=392)
| Variables | Sample total n (%) | Fatigue n (%) | χ2 | P value | |
| Yes | No | ||||
| Type of HAART regimen | |||||
| AZT+3TC+NVP | 155 (39.5) | 74 (47.7) | 81 (52.3) | 1.3 | 0.7 |
| AZT+3TC+EFV | 16 (4.1) | 7 (43.8) | 9 (56.2) | ||
| TDF+3TC+EFV | 118 (30.1) | 76 (64.4) | 62 (35.6) | ||
| TDF+3TC+NVP | 63 (16.1) | 27 (42.9) | 36 (57.1) | ||
| ABC+DDI+LPV/R | 19 (4.8) | 14 (73.7) | 05 (26.3) | ||
| Pre-HAART | 21 (5.4) | 11 (52.4) | 10 (47.6) | ||
| CD4 counts | |||||
| <200 cells/mm3 | 23 (5.8) | 07 (30.4) | 16 (69.6) | 4.5 | 0.23 |
| 200–350 cells/mm3 | 228 (58.2) | 128 (56.1) | 100 (43.9) | ||
| >350 cells/mm3 | 141 (36.0) | 73 (51.8) | 68 (48.2) | ||
| Duration of HIV infection | |||||
| <60 months | 232 (59.2) | 176 (75.9) | 56 (24.1) | 119.7 | 0.000 |
| 60–100 months | 87 (22.2) | 24 (27.6) | 63 (72.4) | ||
| >100 months | 73 (18.6) | 09 (12.3) | 64 (87.7) | ||
| WHO HIV/AIDS clinical stage | |||||
| Stage I | 230 (58.7) | 99 (43) | 131 (57) | 25.1 | 0.00 |
| Stage II | 80 (20.4) | 51 (63.8) | 29 (36.2) | ||
| Stage III | 81 (20.7) | 58 (71.6) | 23 (28.4) | ||
| Stage IV | 1 (0.3) | 01 (100) | 0 (0) | ||
| Weight loss | |||||
| No weight loss | 26 (6.6) | 24 (92.3) | 02 (7.7) | 31.9 | 0.01 |
| Mild weight loss | 148 (37.8) | 102 (68.9) | 46 (31.1) | ||
| Moderate weight loss | 122 (31.1) | 63 (51.6) | 59 (48.4) | ||
| Severe weight loss | 96 (24.5) | 20 (20.8) | 76 (79.2) | ||
| Anaemic | |||||
| Yes | 191 (48.7) | 180 (94.2) | 11 (5.8) | 111.2 | 0.000 |
| No | 201 (51.3) | 29 (14.4) | 172 (85.6) | ||
| Diabetes mellitus | |||||
| Yes | 18 (4.6) | 15 (83.3) | 03 (16.7) | 13.6 | 0.001 |
| No | 374 (95.4) | 194 (51.9) | 180 (48.1) | ||
| Hypertension | |||||
| Yes | 11 (9.4) | 10 (90.8) | 01 (9.1) | 9.2 | 0.002 |
| No | 381 (89.6) | 198 (52) | 183 (48) | ||
| Other comorbid conditions | |||||
| Yes | 37 (9.4) | 23 (62.2) | 14 (37.8) | 15.3 | 0.000 |
| No | 355 (90.6) | 186 (52.4) | 169 (47.6) | ||
| Depression | |||||
| Yes | 283 | 204 (72.1) | 79 (27.9) | 144.8 | 0.000 |
| No | 109 (28.1) | 21 (19.3) | 88 (80.7) | ||
| Insomnia | |||||
| Yes | 91 (23.2) | 43 (47.3) | 48 (52.7) | 1.66 | 0.68 |
| No | 30 (76.8) | 166 (55.1) | 135 (44.9) | ||
| Physical activity | |||||
| Yes | 117 (29.8) | 41 (35.1) | 76 (64.9) | 5.49 | 0.014 |
| No | 275 (70.2) | 178 (64.7) | 97 (35.3) | ||
| Physical disability | |||||
| Yes | 12 (3.1) | 10 (83.3) | 02 (16.7) | 2.48 | 0.59 |
| No | 380 (96.9) | 199 (52.4) | 181 (47.8) | ||
HAART, highly active antiretroviral therapy.